Literature DB >> 20218015

Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

D P Vaughan1, I Hope.   

Abstract

General equations for the time integral on [0, infinity) of the venous drug concentration-time function after intravenous and oral drug administration are derived. A physiologically realistic stochastic recirculating model is applied in the derivations. The quotient of the intravenous drug dose and the integral on [0, infinity) of the resulting venous blood drug concentration function is equivalent to a summation of organ clearances only provided that drug elimination does not occur in the pulmonary system, and in general it is not equivalent to "total body clearance." In general, mammillary compartmental models are not isomorphic with recirculating models. A necessary condition for isomorphism is that the pulmonary system be conservative toward the drug. Equations for the pulmonary "first-pass" effect derived via the compartmental analysis are invalid. A valid expression for the pulmonary "first-pass" effect is derived. General equations derived via compartmental analysis for the extent of hepatic metabolism and the hepatic first-pass" effect are shown to be valid. A generally applicable expression for the advantage of close intraarterial drug administration is derived. The limitations of compartmental models for representing drug distribution and elimination are discussed, and the advantages of recirculating models are emphasized.

Mesh:

Year:  1979        PMID: 20218015     DOI: 10.1007/bf01059739

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  24 in total

1.  Quantitation of hepatic and pulmonary first-pass effects and its implications in pharmacokinetic study. I. Pharmacokinetics of chloroform in man.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  THE SIGNIFICANCE OF THE DIFFERENCE IN SYSTEMIC ARTERIAL AND VENOUS PLASMA CONCENTRATIONS IN RENAL CLEARANCE METHODS.

Authors:  C Brun; T Hilden; F Raaschou
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

3.  A general equation for the ratio of the areas below the blood or plasma concentration time-curves following intravenous and oral drug administration and its application to inter-subject variations in drug elimination.

Authors:  D P Vaughan; A Trainor
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

4.  Animal scale-up.

Authors:  R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1973-10

5.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

6.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

7.  Thiopental pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

8.  Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

9.  Analysis of tracer experiments. 8. Integro-differential equation treatment of partly accessible, partly injectable multicompartment systems.

Authors:  H E Hart
Journal:  Bull Math Biophys       Date:  1967-06

10.  STUDIES OF UREA EXCRETION. II: Relationship Between Urine Volume and the Rate of Urea Excretion by Normal Adults.

Authors:  E Möller; J F McIntosh; D D Van Slyke
Journal:  J Clin Invest       Date:  1928-12       Impact factor: 14.808

View more
  17 in total

1.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Statistical moments and disposition parameters in a local perfusion system under mammillary nonequilibrium condition.

Authors:  T Kakutani; E Nara; M Hashida
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

3.  Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement.

Authors:  R Mehvar
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 4.  Systems dynamics in clinical pharmacokinetics. An introduction.

Authors:  J M van Rossum; J E de Bie
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

Review 5.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

Review 6.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

7.  Pharmacokinetics from a dynamical systems point of view.

Authors:  J M van Rossum; J E de Bie; G van Lingen; H W Teeuwen
Journal:  J Pharmacokinet Biopharm       Date:  1989-06

8.  Pharmacokinetic stochastic model with Weibull-distributed residence times of drug molecules in the body.

Authors:  V K Piotrovskii
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 9.  Current models in pharmacokinetics: applications in veterinary pharmacology.

Authors:  L D Kinabo; Q A McKellar
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

10.  A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems.

Authors:  T Kakutani; K Yamaoka; M Hashida; H Sezaki
Journal:  J Pharmacokinet Biopharm       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.